Liam Nagle News Today

The Newry veterinary pharmaceuticals group Norbrook saw it profits squeezed to the lowest level in more than a decade during 2023, as the company faced increased competition from India and China.

Adam Tranter believes the plans to tackle “reckless” and anti-social behaviour by banning e-bikes in Coventry’s pedestrianised areas “will bring unintended consequences for active travel”

THE former chief executive of Invest NI has unexpectedly stepped down from his high profile role at Newry pharmaceutical giant Norbrook Laboratories after little more than a year.

Officers from West Midlands Police will be “engaging with delivery riders” in Coventry City Centre next week in response to rising complaints about the behaviour of e-bike riders. The force has warned that any riders flouting the law could be prosecuted. Coventry currently has a public space protection order (PSPO) in place, stipulating that people must cycle in a "careful and

The Newry headquartered pharmaceutical firm, Norbrook, which manufactures a portfolio of animal health products, plans to cut 180 jobs.

NEWRY pharma giant Norbrook is making 180 workers redundant as part of what it says are “significant changes in its operating environment”.

The pharmaceutical firm is one of NI's biggest exporters but faces "global economic challenges".

The pharmaceutical firm's profits fell by 21% to £21.3m, with a marginal rise in turnover.

Norbrook: Covid-19 hits profits at Newry pharmaceutical firm By John Campbell Published image copyrightPacemaker Norbrook Holdings, the Newry-based pharmaceutical firm, saw its pre-tax profits almost halve to £4.2m in the past year. Output was disrupted by the effect of the pandemic in the first half of the financial year. Chief executive Liam Nagle said the firm lost 20% of its manufacturing capacity for a four-month period. He said investments in factories and staff facilities allowed a retu...